chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been rec'd from a RN concerning a pt with no past medical history or known allergies who on 6/1/00 was vaccinated SC in the R arm with a 1st dose of varicella virus vaccine live (lot#46376051849J). On 6/9/00 the pt developed red, raised bumps at the injection site. Unspecified medical attention was sought. It was noted that the pt was afebrile and that the injection site reaction was approximately  the size of a nickel. No further information is available.
Sore neck; dizziness; pins and needles feeling while standing; Pressure feeling behind eyes; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 02Apr2021 at 14:15 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history included epilepsy and COVID-19. Concomitant medications included valproate semisodium (DEPAKOTE ER) from an unknown date, for an unknown indication. The patient previously took Lamictal and experienced allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 03:00 the patient experienced sore neck, dizziness, pins and needles feeling while standing and pressure feeling behind eyes.  The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events of sore neck, dizziness, pins and needles feeling while standing and pressure feeling behind eyes was recovering at the time of the report.  No follow-up attempts are needed. No further information is expected.
15 post vaccination started to complain of her lips tingling. It progressed to itchy eyes and started getting a little itchy all over. Her lips went from feeling itchy to feeling waxy. Gave benadryl at 5;15 pm. Patient started felling less itchy and lips were feeling a little better at 5:30. continues to monitor patient until 5:45pm patient stated she was feeling better and felt comfortable going home. Patient left clinic at 5:50pm. Called and checked on patient at 7:00pm and she stated all symptoms were gone that she was just tired from the benadryl
I got exposed to COVID on 5/8/2022. Then on 5/10/2022, I started getting symptoms of mild sore throat, sneezing, slight headache, and muscle aches. I went to an urgent care and received a positive COVID-19 test. My symptoms stayed the same. My symptoms are still lingering with sneezing and nasal burning into my eyes. I did a home test today and I am still testing positive.
Started feeling tired, developed chills to the point teeth were chattering even under covers, chills ended after about 8 hours, tiredness ended by about 36 hours after shot - perfectly good 48 hours after shot given (felt great)
This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# EN6202 and expiration date not reported), at the vaccination age of 69, via an unspecified route of administration, left arm, on Feb 26, 2021, at 16:30, single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. Patient has no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Patient did not take any other medication in two weeks. The patient has not tested for COVID-19 since the vaccination. On Mar 1, 2021, patient reported itchy rash on upper back, chills/fever, nausea and a general feeling of being unwell. The patient did not receive any treatment due to adverse events. The outcome of all the events: recovering. No follow-up attempts possible. No further information expected.
Stroke affecting speech & cognitive thinking.  A Thrombectomy was performed by a doctor at hospital.  I was not able to speak, write, or type in any way that was understandable by anyone.  I also had weakness on the right side of my body.  After the procedure, I was kept in the hospital for 5 days to try determine the cause & to evaluate any necessary therapy needs.
mid january 2004 - smallpox scar gradually increased in size to 15mm, reddened keloid - type raised area. Pt is 22wks pregnant - saw ??  OB today, referred to LHD for explanation. Pt is an RN. She worked in an ER at time of vaccination.
Approximately 15-20 minutes after receiving vaccines, child started breaking out with hives. Hives were on his trunk, arms, neck and face. Child was given 0.3 ml of diphenhydramine IM in the R thigh. Child was observed for approximately 40 minutes. During this time, the hives became noticeably less. Mother and child left the clinic.
Left arm rashed and painful. Fever of 101.6 for three days. Rash remained for one week. Still painful and swollen. Less though. Resolving.
Moderna COVID-19 vaccine eua-- only slight -moderate injection site pain for  the first 8 hrs (3/18/21)- then chills and shakes and sweating through the first night. the next day random dizziness and aching joints every where (3/19/20)- slight dizziness and warmness around throat and ears. 3/20/21
Patient received influenza vaccination on 10-12-11 and reports the upper arm began to hurt about 1 hr. after injection and continues to be "stiff" with discomfort, especially when raising the LUE above her head.
tingling in the R arm and leg; swelling in the R side of the face/cheek Narrative: Employee reports after having vaccine felt tingling in her R arm; later R leg and facial/ cheek swelling on the Right side. Remained the same overnight and was seen the next day 12/29/2020. Benadryl order and employee sent home
About 7 hours post-admninistration, I awoke in the middle of the night with debilitating shoulder pain. I was unable to move my shoulder and had little to no range of motion. While I knew that I would experience injection site pain (considering I've received countless vaccinations including the first two doses of the COVID-19 vaccine), this was different as this was in my shoulder bursa, and I was unable to move my arm. I tried taking painkillers and using ice, to no avail. I tried doing small range of motion exercises by lifting my left arm up using my right hand, to no avail as it only made the pain sharper and worse. For the next 6 days I continue to have debilitating shoulder pain, and am making an appointment with my orthopedist. As someone who has given vaccines throughout the pandemic, I know that this was not a problem with the vaccine, but with the injector's lack of skill and/or carelessness. She did not use the correct method to landmark the injection site (such as the Z-track method), and over-confidently injected way too high up on my arm and straight into the bursa resulting in SIRVA (or a SIRVA-like reaction). I still do not have even close to full function in the arm. Any muscular soreness has gone away but the joint pain/bursa pain has not.
Patient was seen on 3/14/23 and was due for third dose of Pfizer 6month to 4years bivalent COVID19 vaccine. In error, patient received Pfizer 6month to 4years monovalent. As per provider, patient was advised to return to office in one month to receive the correct Pfizer vaccine.
Developed persistent abdominal pain with diarrhea. Has continued to have abdominal discomfort and diarrhea (1 bowel movement/day) for approximately 2 weeks.
no adverse event; 3 pediatric patients received the vaccine after more than 12 hours post puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 pediatric patients received the vaccine after more than 12 hours post puncture) and NO ADVERSE EVENT (no adverse event) in an 8-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9236B) for COVID-19 vaccination. No Medical History information was reported. On 10-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 10-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (3 pediatric patients received the vaccine after more than 12 hours post puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (3 pediatric patients received the vaccine after more than 12 hours post puncture) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (3 pediatric patients received the vaccine after more than 12 hours post puncture).    No concomitant medications were reported. Vail size was reported as 2.5 mL. Vial was initially stored in the refrigerator on 5 OCT-2022. It was first punctured on 08-OCT-2022 9:15 am and vaccine was administered on 10-OCT-2022 on 10:45 am, 11:15 am and 3:30 pm. Vial was stored in fridge post puncture. Vial did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8 to 25 degree Celsius-46 to 77 degree Fahrenheit) was less than 10 minutes. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-657574, US-MODERNATX, INC.-MOD-2022-657611 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-657574:same reporter US-MODERNATX, INC.-MOD-2022-657611:same reporter.
Got an allergic rash on arm and on body - went to Dr. - got prednisone from Dr.
From initial info received at manufacturer on 02/06/2003, it was reported that a 28-year-old female pt received Imovax Rabies, lot number T0122-2, given intra-muscular in the right deltoid, expiration date for this product is 02/16/2003, on 02/05/2003. On same day as vaccination, pt stated that she felt dizzy and nauseated right away. Pt developed a headache and by the next day she developed welts over her body. Pt took 4 Benadryl and used her inhaler for her breathing. Pt has allergies and an epinephrine, she used that. Pt still has dizziness and nausea.
Information has been received from a healthcare worker via a company representative referring to an adolescent male child of unknown age. The patient's medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with a dose of GARDASIL 9 (dose, dose number, lot# and expiration date unknown, intramuscular). Concomitant medication was not reported. On unknown dates the patient experienced pain at injection site and radiating numbness down the right arm. The patient called doctor's office. No lab diagnostics studies were performed and no treatment was given for the events. The pain and numbness subsided after one week. Finally, the patient recovered from the events (dates unknown). Additional information has been requested.
PATIENT STATES HAS INFECTION IN LEFT ARM, HAS BEEN TO MD AND HAS BEEN PRESCRIBED UNKNOWN ANTIBIOTICS.
Light headed, dizziness, flushed  11:47 AM  Vital Signs: BP 154/98 HR 82 Resp 16 O2sat 96% AOx3  Skin Signs: Warm and dry  Circulation: 1 sec  Respiratory: Breath sound clear bilaterally  Initial Treatment: Patient escorted to triage area, provided water, denies shortness of breath. Patient chose to sit rather than lay down.  12:02 PM Vital Signs: BP 130/88 HR 79 Resp 12 O2sat 98% AOx3  Skin Signs: Warm and dry  Circulation: 1 sec  Respiratory: Breath sound clear bilaterally  12:16 PM  Vital Signs: BP 146/98 HR 62 Resp 12 O2sat 96% AOx3  Skin Signs: Warm and dry  Circulation: 1 sec  Respiratory: Breath sound clear bilaterally  1st vital signs - Patient verbalized feeling dizzy and flushed  2nd vital signs: Verbalized she was feeling better. Denies dizziness, not flushing, skin pink, warm and dry, clear breath sounds bilaterally, no shortness of breath, AOx3  On final assessment - Patient states 'I feel much better, the water helped' AOx3, P/W/D, denies dizziness, BS clear x4, cap refill less than 1, no SOB. Reviewed common reactions to vaccine, encouraging patient to rest and drink fluids.  Home accompanied by husband.
Developed anaphylaxis consisting of vomiting twice about 5 and 20 minutes after administration; progressed to periorbital swelling, incessant coughing, erythroderma, decreasing blood pressure; treated in office with Epipen Jr. injections two times at 1:15 and 1:30 apart as well as diphenhydramine 12.5 mg IM and blowby oxygen. EMS was previously notified, arrived, and transported him to nearby hospital where he received IV fluids, corticosteroids, and proton pump inhibitor, and other ongoing management.
Ears are ringing since the day after the injection; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 25Mar2021 (at the age of 55-years-old) as a single dose for COVID-19 immunization. Medical history included obese (obesity) and latex allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on an unknown date as a single dose for COVID-19 immunization. On 26Mar2021 at 20:00, since the day after the injection the patient felt ears were ringing. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ears is ringing since the day after the injection was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Prior to receiving my second COVID shot on 03/15/2021, I was running 3-4 miles a minimum of 5 days a week. After my shot my joints started swelling, and hurting  severely, so severely that I couldn't run. I attempted multiple times and hoped it would wear off, but it has continued. When I exercise my hands and feet swell to 3 times their normal size. The swelling will remain for approximately 2 hours  after, with a slow decrease of fluid. When I wake up in the morning, my feet and hands hurt so bad that I can hardly walk.
Initial information received on 06-Nov-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 91-year-old male patient who was vaccinated with an expired dose of INFLUENZA QUADRIVAL A-B VACCINE (batch number: UI879AA, expiration date: 30-Jun-2018) via intramuscular in left deltoid, on 06-Nov-2018. The patient's medical history and concomitant medications were not reported. It was an actual medication error due to expired vaccine used. The patient had no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Less than 12 hours after administering shot patients arm became sore to touch and red on injection site. Also, had a knot under the skin. By the 02/21/2018 mom called to report that the entire arm was hurting, it felt "heavier" and the redness had spread and the most part of his upper arm and the knot under his arm was larger. We recommended for patient to ice his arm, taking TYLENOL and to also take BENADRYL for the allergic reaction. By 2/23/2018 all affects from medication had resolved.
Couldn't walk; Terrible body aches; Every joint was aching; Mild, headache; Cold with chills; Cold with chills/ Was shivering; Fever; Sweating all night; This is a spontaneous report from a contactable nurse. A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number and expiry date unknown, via an unspecified route of administration on 31Dec2020 10:02 at a SINGLE DOSE for covid-19 immunisation. Medical history included tuberculosis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took BCG vaccine. The patient received Pfizer COVID Vaccine on 31Dec2020. On 04Jan2021, the patient got a couple of symptoms and started with a mild headache, not sharp pain and she took Tylenol. After she showered when she came home from work, she got chills. She took a couple more Tylenol, but doesn't know when. When she went to bed, she sweated all night and still feel cold with chills and was sweating all night. She didn't really check temperature, but knew she had a fever. On 05Jan2021, she woke up and felt like someone had hit her from her head to toes and every joint was aching, terrible body aches and couldn't walk. She went to emergency room on 05Jan2021 and thought she may have been exposed a couple of days before. She was working with patients who had COVID. She had a rapid COVID test that was negative and came home and symptoms continued. Today was the first day she was feeling a little better. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on an unspecified date. Therapeutic measures were taken as a result of mild, headache, cold with chills, cold with chills/ was shivering, fever, sweating all night , couldn't walk, terrible body aches, every joint was aching. The outcome of the events was unknown.  Information was requested on Lot/ Batch number.
The consumer reported that she uses a walker; "extreme dizziness"; Moderna vaccine may be "reacting" with her daily medications; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS ("extreme dizziness"), DRUG INTERACTION (Moderna vaccine may be "reacting" with her daily medications) and WALKING AID USER (The consumer reported that she uses a walker) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A or 027B21A) for COVID-19 immunisation.     No medical history was provided by the reporter.  Concurrent medical conditions included Blood pressure high, Mental tension, Drug allergy and Drug allergy. Concomitant products included LEVETIRACETAM, venlafaxine ER, QUETIAPINE FUMARATE (SEROQUEL), QUINAPRIL, FLUVOXAMINE and Metamucil for an unknown indication.   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced DIZZINESS ("extreme dizziness") and DRUG INTERACTION (Moderna vaccine may be "reacting" with her daily medications). On an unknown date, the patient experienced WALKING AID USER (The consumer reported that she uses a walker). At the time of the report, DIZZINESS ("extreme dizziness"), DRUG INTERACTION (Moderna vaccine may be "reacting" with her daily medications) and WALKING AID USER (The consumer reported that she uses a walker) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.
itch; pain; This case was reported by a other health professional via interactive digital media and described the occurrence of pruritus in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pruritus and pain. On an unknown date, the outcome of the pruritus and pain were unknown.   It was unknown if the reporter considered the pruritus and pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The reporter stated that, after vaccination, the patient had itch and pain.
Pt is a 37 year old male who reported no problems with his health until early Feb 05. He stated he was vaccinated for anthrax and when questioned because his records showed he received small pox and declined anthrax, he stated that he was told to keep the area covered until the scab came off and to take precautions with laundry. He initially reported problems with night sweats and problems breathing and stated he was eventually diagnosed with sarcoidosis. He stated he took steroids and methotrexate and began to feel better and was eventually cleared to deploy with his unit in Oct. He received additional immunizations, but does not recall which ones but stated he had no problems following subsequent immunizations. In Dec 05 he experienced a sudden onset of weakness on the right side of face, along with problems closing his eye, and drooling, He also noted at the same time hearing loss and headaches on the right side of his head. He denied these symptoms prior to the onset of facial weakness and sought immediate medical attention. He was diagnosed with Bells palsy and eventually returned to state side. He reports continued problems with the headaches and facial weakness and states that there is little improvement in his symptoms despite taking the medication. He reports the headaches are no constant, whereas it would have pain free periods the first month, on the right side of his head rated # on scale of 1-10 and 10 being worse. He stated at times the pain may reach 10 and it sometimes wakes him up at night. He stated it is like a giant toothache and is always there, never pain free and stated Midrin helps only a little, He denies photosensitivity, nausea, altered sensation, and neck pain. He stated that his hearing problem started with the onset of his Bells palsy and that he occasionally has ringing in his right ear only, especially when his headache is severe. Clamminess 02/2005, dyspnea (shortness of breath) 02/2005, Facial nerve paralysis/palsy 12/2005, head pain 12/2005 comment rt side of head. Hearing loss 12/2005
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. On 09-APR-2013, the patient was inadvertently vaccinated with a dose of ZOSTAVAX (lot number reported as 0567AE), subcutaneously that had expired on 04-APR-2013. No concomitant medications were reported. No adverse effects were reported. Additional information is not expected.